134 related articles for article (PubMed ID: 21969106)
1. Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption.
Wolff K; Tsapakis EM; Pariante CM; Kerwin RW; Forsling ML; Aitchison KJ
J Psychopharmacol; 2012 Mar; 26(3):419-28. PubMed ID: 21969106
[TBL] [Abstract][Full Text] [Related]
2. Ecstasy (MDMA)-induced hyponatraemia is associated with genetic variants in CYP2D6 and COMT.
Aitchison KJ; Tsapakis EM; Huezo-Diaz P; Kerwin RW; Forsling ML; Wolff K
J Psychopharmacol; 2012 Mar; 26(3):408-18. PubMed ID: 22303032
[TBL] [Abstract][Full Text] [Related]
3. MDMA can increase cortisol levels by 800% in dance clubbers.
Parrott A; Lock J; Adnum L; Thome J
J Psychopharmacol; 2013 Jan; 27(1):113-4. PubMed ID: 23255436
[No Abstract] [Full Text] [Related]
4. Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT).
Pardo-Lozano R; Farré M; Yubero-Lahoz S; O'Mathúna B; Torrens M; Mustata C; Pérez-Mañá C; Langohr K; Cuyàs E; Carbó Ml; de la Torre R
PLoS One; 2012; 7(10):e47599. PubMed ID: 23112822
[TBL] [Abstract][Full Text] [Related]
5. Reply to 'MDMA can increase cortical levels by 800% in dance clubbers' Parrott et al.
Wolff K; Aitchison K
J Psychopharmacol; 2013 Jan; 27(1):115-6. PubMed ID: 23255437
[No Abstract] [Full Text] [Related]
6. MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy.
Parrott AC; Moore DG; Turner JJ; Goodwin J; Min MO; Singer LT
Hum Psychopharmacol; 2014 Jan; 29(1):1-7. PubMed ID: 24424703
[TBL] [Abstract][Full Text] [Related]
7. The relationships among MAOA, COMT Val158Met, and 5-HTTLPR polymorphisms, newborn stress reactivity, and infant temperament.
Bajgarova Z; Bajgar A
Brain Behav; 2020 Feb; 10(2):e01511. PubMed ID: 31884721
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.
Yubero-Lahoz S; Pardo R; Farré M; O'Mahony B; Torrens M; Mustata C; Pérez-Mañá C; Carbó ML; de la Torre R
Clin Pharmacokinet; 2011 May; 50(5):319-29. PubMed ID: 21456632
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-pituitary-adrenal axis responses to stress in subjects with 3,4-methylenedioxy-methamphetamine ('ecstasy') use history: correlation with dopamine receptor sensitivity.
Gerra G; Bassignana S; Zaimovic A; Moi G; Bussandri M; Caccavari R; Brambilla F; Molina E
Psychiatry Res; 2003 Sep; 120(2):115-24. PubMed ID: 14527643
[TBL] [Abstract][Full Text] [Related]
10. Catechol-O-Methyltransferase gene (val158met) polymorphisms and anxious symptoms in early childhood: The roles of hypothalamus-pituitary-adrenal axis reactivity and life stress.
Sheikh HI; Kryski KR; Kotelnikova Y; Hayden EP; Singh SM
Neurosci Lett; 2017 Oct; 659():86-91. PubMed ID: 28859863
[TBL] [Abstract][Full Text] [Related]
11. In abstinent MDMA users the cortisol awakening response is off-set but associated with prefrontal serotonin transporter binding as in non-users.
Frokjaer VG; Erritzoe D; Holst KK; Madsen KS; Fisher PM; Madsen J; Svarer C; Knudsen GM
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1119-28. PubMed ID: 24524290
[TBL] [Abstract][Full Text] [Related]
12. Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes.
Parrott AC; Lock J; Conner AC; Kissling C; Thome J
Neuropsychobiology; 2008; 57(4):165-80. PubMed ID: 18654086
[TBL] [Abstract][Full Text] [Related]
13. Oxytocin, cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of recreational 'ecstasy'.
Parrott AC
Behav Pharmacol; 2016 Dec; 27(8):649-658. PubMed ID: 27681116
[TBL] [Abstract][Full Text] [Related]
14. Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA.
Yang J; Jamei M; Heydari A; Yeo KR; de la Torre R; Farré M; Tucker GT; Rostami-Hodjegan A
J Psychopharmacol; 2006 Nov; 20(6):842-9. PubMed ID: 16714321
[TBL] [Abstract][Full Text] [Related]
15. Serotonin transporter gene methylation predicts long-term cortisol concentrations in hair.
Alexander N; Illius S; Stalder T; Wankerl M; Muehlhan M; Kirschbaum C
Psychoneuroendocrinology; 2019 Aug; 106():179-182. PubMed ID: 30999228
[TBL] [Abstract][Full Text] [Related]
16. Increased cortisol levels in hair of recent Ecstasy/MDMA users.
Parrott AC; Sands HR; Jones L; Clow A; Evans P; Downey LA; Stalder T
Eur Neuropsychopharmacol; 2014 Mar; 24(3):369-74. PubMed ID: 24333019
[TBL] [Abstract][Full Text] [Related]
17. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
Colado MI; Williams JL; Green AR
Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
[TBL] [Abstract][Full Text] [Related]
18. MDMA, cortisol, and heightened stress in recreational ecstasy users.
Parrott AC; Montgomery C; Wetherell MA; Downey LA; Stough C; Scholey AB
Behav Pharmacol; 2014 Sep; 25(5-6):458-72. PubMed ID: 25014666
[TBL] [Abstract][Full Text] [Related]
19. Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
Wetherell MA; Montgomery C
Psychopharmacology (Berl); 2014 Apr; 231(7):1365-75. PubMed ID: 24190587
[TBL] [Abstract][Full Text] [Related]
20. Interaction between gene variants of the serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT) in borderline personality disorder.
Tadić A; Victor A; Başkaya O; von Cube R; Hoch J; Kouti I; Anicker NJ; Höppner W; Lieb K; Dahmen N
Am J Med Genet B Neuropsychiatr Genet; 2009 Jun; 150B(4):487-95. PubMed ID: 18756498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
